These data indicated that BC patients with BRCA1 c.5309G>T and BRCA2 c.1310_1313delAAGA mutations had poor survival outcomes and hence screening patients with BC for BRCA mutations might help in strategizing their treatment and improving their survival. This evidence concerns the gene BRCA1 and breast cancer.